Novartis is investing in a novel type of medicine to reduce the risk of heart disease.

Novartis investigators find genetic explanations for why some young patients relapse.

Combination of two compounds shows promise in the lab

Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.

Novartis researchers are peering deep inside knees to see if regenerated cartilage is springy like natural cartilage.

Cambridge neighbors, NIBR and Harvard, further disrupt technology. Read how their alliance is accelerating drug discovery.

Chief Talent and People Solutions Officer Tripti Jha’s mother prioritized her learning in a rural region of India with limited opportunities for girls.

A conversation with Novartis Chief Digital Officer Bertrand Bodson

Patrice Matchaba shares how a lifetime of experience helped shape an effort to address healthcare disparities.